Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals PLC has repurchased 623,461 of its ordinary shares on the London Stock Exchange between July 27 and July 31, 2026, as part of its $250 million share buyback program. The average price paid per share was approximately 1,595.40 pence. The company intends to cancel these repurchased shares, which will result in 210,142,206 ordinary shares outstanding.

Disclaimer*

UK 100

Latest directors dealings